cardio Flashcards
You are a CT1 in Acute Medicine covering the hospital at night. You are called to the surgical ward to see a 35-year-old patient who is reporting palpitations. She is known to have Wolff-Parkinson-White syndrome. Her ECG shows fast atrial fibrillation. On examination, there is no evidence of haemodynamic instability. What is the most appropriate pharmacological management option for this patient?
Verapamil
Avoid AV node blockade (dig or bisop) in accessory pathways
What does troponin T bind to?
Tropomyosin is a protein which regulates actin. It associates with actin in muscle fibres and regulates muscle contraction by regulating the binding of myosin.
Features suggesting VT rather than SVT with aberrant conduction
AV dissociation fusion or capture beats positive QRS concordance in chest leads marked left axis deviation history of IHD lack of response to adenosine or carotid sinus massage QRS > 160 ms
Major bleeding on warfarin
stop warfarin, give intravenous vitamin K 5mg, prothrombin complex concentrate
Hypokalaemia ECG
U waves small or absent T waves (occasionally inversion) prolong PR interval ST depression long QT
Second heart sound (S2)
loud: hypertension
soft: AS
fixed split: ASD
reversed split: LBBB
Irregular Cannon A waves vs Regular
Caused by the right atrium contracting against a closed tricuspid valve. May be subdivided into regular or intermittent
Regular cannon waves ventricular tachycardia (with 1:1 ventricular-atrial conduction) atrio-ventricular nodal re-entry tachycardia (AVNRT)
Irregular cannon waves
complete heart block
Strep viridians vegetation eradication
IV benpen
fusion and capture beats
suggest VT
Amiodarone first line
Hypertrophic obstructive cardiomyopathy Mx
Management Amiodarone Beta-blockers or verapamil for symptoms Cardioverter defibrillator Dual chamber pacemaker Endocarditis prophylaxis*
Drugs to avoid
nitrates
ACE-inhibitors
inotropes
Strep viridians vegetation eradication
IV benpen
fusion and capture beats
suggest VT
Amiodarone first line
Hypertrophic obstructive cardiomyopathy Mx
Management Amiodarone Beta-blockers or verapamil for symptoms Cardioverter defibrillator Dual chamber pacemaker Endocarditis prophylaxis*
Drugs to avoid
nitrates
ACE-inhibitors
inotropes
poor prognostic in ACS
age development (or history) of heart failure peripheral vascular disease reduced systolic blood pressure Killip class* initial serum creatinine concentration elevated initial cardiac markers cardiac arrest on admission ST segment deviation
*Killip class - system used to stratify risk post myocardial infarction
Killip class Features 30 day mortality I No clinical signs heart failure 6% II Lung crackles, S3 17% III Frank pulmonary oedema 38% IV Cardiogenic shock 81%
Eisenmenger’s syndrome
Eisenmenger’s syndrome describes the reversal of a left-to-right shunt in a congenital heart defect due to pulmonary hypertension. This occurs when an uncorrected left-to-right leads to remodeling of the pulmonary microvasculature, eventually causing obstruction to pulmonary blood and pulmonary hypertension.
Associated with
ventricular septal defect
atrial septal defect
patent ductus arteriosus
Features original murmur may disappear cyanosis clubbing right ventricular failure haemoptysis, embolism
Management
heart-lung transplantation is required
brugada syndrome
Pathophysiology
a large number of variants exist
around 20-40% of cases are caused by a mutation in the SCN5A gene which encodes the myocardial sodium ion channel protein
ECG changes
convex ST segment elevation > 2mm in > 1 of V1-V3 followed by a negative T wave
partial right bundle branch block
the ECG changes may be more apparent following the administration of flecainide or ajmaline - this is the investigation of choice in suspected cases of Brugada syndrome
Management
implantable cardioverter-defibrillator
poor prognostic in ACS
age development (or history) of heart failure peripheral vascular disease reduced systolic blood pressure Killip class* initial serum creatinine concentration elevated initial cardiac markers cardiac arrest on admission ST segment deviation
*Killip class - system used to stratify risk post myocardial infarction
Killip class Features 30 day mortality I No clinical signs heart failure 6% II Lung crackles, S3 17% III Frank pulmonary oedema 38% IV Cardiogenic shock 81%
Pulmonary arterial HTN
Management
Management should first involve treating any underlying conditions, for example with anticoagulants or oxygen. Following this, it has now been shown that acute vasodilator testing is central to deciding on the appropriate management strategy. Acute vasodilator testing aims to decide which patients show a significant fall in pulmonary arterial pressure following the administration of vasodilators such as intravenous epoprostenol or inhaled nitric oxide.
If there is a positive response to acute vasodilator testing (a minority of patients)
oral calcium channel blockers
If there is a negative response to acute vasodilator testing (the vast majority of patients)
prostacyclin analogues: treprostinil, iloprost
endothelin receptor antagonists: bosentan, ambrisentan
phosphodiesterase inhibitors: sildenafil
Patients with progressive symptoms should be considered for a heart-lung transplant.
Search
Search textbook…
Links
European Society of Cardiology42
2015 Guidelines for the diagnosis and treatment of pulmonary hypertension
Respiratory Medicine journal36
Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension
Suggest linkReport broken link Media YouTube Pulmonary hypertension Osmosis - YouTube263
Intravenous glycoprotein IIb/IIIa receptor antagonists
should be given to patients who have an intermediate or higher risk of adverse cardiovascular events (predicted 6-month mortality above 3.0%), and who are scheduled to undergo angiography within 96 hours of hospital admission.
Pulmonary arterial hypertension
features
progressive exertional dyspnoea is the classical presentation
other possible features include exertional syncope, exertional chest pain and peripheral oedema
cyanosis
right ventricular heave, loud P2, raised JVP with prominent ‘a’ waves, tricuspid regurgitation
Pulmonary arterial HTN
Management
Management should first involve treating any underlying conditions, for example with anticoagulants or oxygen. Following this, it has now been shown that acute vasodilator testing is central to deciding on the appropriate management strategy. Acute vasodilator testing aims to decide which patients show a significant fall in pulmonary arterial pressure following the administration of vasodilators such as intravenous epoprostenol or inhaled nitric oxide.
If there is a positive response to acute vasodilator testing (a minority of patients)
oral calcium channel blockers
If there is a negative response to acute vasodilator testing (the vast majority of patients)
prostacyclin analogues: treprostinil, iloprost
endothelin receptor antagonists: bosentan, ambrisentan
phosphodiesterase inhibitors: sildenafil
Patients with progressive symptoms should be considered for a heart-lung transplant.
Search
Search textbook…
Links
European Society of Cardiology42
2015 Guidelines for the diagnosis and treatment of pulmonary hypertension
Respiratory Medicine journal36
Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension
Suggest linkReport broken link Media YouTube Pulmonary hypertension Osmosis - YouTube263
Infective endocarditis - indications for surgery:
severe valvular incompetence
aortic abscess (often indicated by a lengthening PR interval)
infections resistant to antibiotics/fungal infections
cardiac failure refractory to standard medical treatment
recurrent emboli after antibiotic therapy
ECG features of Digoxin
down-sloping ST depression (‘reverse tick’)
flattened/inverted T waves
short QT interval
arrhythmias e.g. AV block, bradycardia
ECG changes - territories
Anteroseptal V1-V4 Left anterior descending
Inferior II, III, aVF Right coronary
Anterolateral V4-6, I, aVL Left anterior descending or left circumflex
Lateral I, aVL +/- V5-6 Left circumflex
Posterior Tall R waves V1-2 Usually left circumflex, also right coronary
Percutaneous coronary intervention
main complications
Two main complications may occur
stent thrombosis: due to platelet aggregation as above. Occurs in 1-2% of patients, most commonly in the first month. Usually presents with acute myocardial infarction
restenosis: due to excessive tissue proliferation around stent. Occurs in around 5-20% of patients, most commonly in the first 3-6 months. Usually presents with the recurrence of angina symptoms. Risk factors include diabetes, renal impairment and stents in venous bypass grafts
Angina first line
A beta-blocker or a calcium channel blocker is used first-line to prevent angina attacks
ACEI for HTN develops angio-oedema and dry cough
Angiotensin-receptor blockers should be used where ACE inhibitors are not tolerated
HTN Mx
insert photo
Most common cause of endocarditis:
Staphylococcus aureus
Staphylococcus epidermidis if < 2 months post valve surgery
4th Heart sound in Aortic Stenosis
A fourth heart sound is sometimes noted during atrial contraction. In aortic stenosis, this is caused by vigorous left atrial contraction against a stiff, non-compliant ventricle.
acute pericarditis ECG changes
Investigations
ECG changes
the changes in pericarditis are often global/widespread, as opposed to the ‘territories’ seen in ischaemic events
‘saddle-shaped’ ST elevation
PR depression: most specific ECG marker for pericarditis
all patients with suspected acute pericarditis should have transthoracic echocardiography
Acute pericarditis Features and Causes
Features
chest pain: may be pleuritic. Is often relieved by sitting forwards
other symptoms include non-productive cough, dyspnoea and flu-like symptoms
pericardial rub
tachypnoea
tachycardia
Causes viral infections (Coxsackie) tuberculosis uraemia (causes 'fibrinous' pericarditis) trauma post-myocardial infarction, Dressler's syndrome connective tissue disease hypothyroidism malignancy
hypothermia ECG
bradycardia 'J' wave - small hump at the end of the QRS complex first degree heart block long QT interval atrial and ventricular arrhythmias
first line Ix for stable chest pain
Contrast-enhanced CT coronary angiogram is the first line investigation for stable chest pain of suspected coronary artery disease aetiology
cholesterol embolisation
Overview
cholesterol emboli may break off causing renal disease
the majority of cases are secondary to vascular surgery or angiography. Other causes include severe atherosclerosis, particularly in large arteries such as the aorta
Features eosinophilia purpura renal failure livedo reticularis
cha2ds2-vasc score
Risk factor Points C Congestive heart failure 1 H Hypertension (or treated hypertension) 1 A2 Age >= 75 years 2 Age 65-74 years 1 D Diabetes 1 S2 Prior Stroke or TIA 2 V Vascular disease (including ischaemic heart disease and peripheral arterial disease) 1 S Sex (female)
Takayasu’s arteritis
Features
systemic features of a vasculitis e.g. malaise, headache
unequal blood pressure in the upper limbs
carotid bruit
intermittent claudication
aortic regurgitation (around 20%)
Associations
renal artery stenosis
Management
steroids
The recommended antibiotic treatment in a patient with a prosthetic valve, no penicillin allergy and staphylococcal endocarditis
flucloxacillin, gentamicin, rifampicin
Pulsus alternans
regular alternations in force of arterial pulse
severe LV dysfunction
ramipril first dose
ramipril can cause first dose hypotension
aortic valve endocarditis worrying ECG change
prolonged PR interval - arotic root abscess
prolonged PR interval
idiopathic ischaemic heart disease digoxin toxicity hypokalaemia* rheumatic fever aortic root pathology e.g. abscess secondary to endocarditis Lyme disease sarcoidosis myotonic dystrophy
AV heart block in what type of MI
inferior MI
coarctation of the aorta features
Features infancy: heart failure adult: hypertension radio-femoral delay mid systolic murmur, maximal over back apical click from the aortic valve notching of the inferior border of the ribs (due to collateral vessels) is not seen in young children
inferior MI which artery?
right coronary artery
bendroflumathiazide side effects
Common adverse effects dehydration postural hypotension hyponatraemia, hypokalaemia, hypercalcaemia* gout impaired glucose tolerance impotence
Rare adverse effects thrombocytopaenia agranulocytosis photosensitivity rash pancreatitis